Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-03

Clinical Trial Update: Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor [Phase 4]

View source ↗

Summary

A Phase 4 study is evaluating whether ticagrelor can reduce microvascular dysfunction after acute myocardial infarction. The document notes the study status as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN